Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

  • Avidan U. Neumann
  • , Nancy P. Lam
  • , Harel Dahari
  • , Marie Davidian
  • , Thelma E. Wiley
  • , Brian P. Mika
  • , Alan S. Perelson
  • , Thomas J. Layden

Research output: Contribution to journalArticlepeer-review

208 Scopus citations

Abstract

Many studies have shown that patients infected with hepatitis C virus (HCV) of genotype 2 have better response to interferon (IFN)-α treatment than genotype 1 patients; however, the mechanisms responsible for this difference are not understood. In this study, viral dynamics during high-dose IFN induction treatment were compared between the genotypes. Patients in each group received 10 MU of IFN-α2b for 14 days, and HCV RNA levels were frequently determined. Nonlinear fitting, both individually for each patient and using a mixed-effects approach, of the viral kinetic data to a mathematical model of the IFN effect on HCV infection was performed. The antiviral effectiveness of IFN in blocking virus production, the free virion clearance rate, and the HCV-infected cell death rate were all significantly higher for genotype 2 patients than for genotype 1 patients. Thus, the better response rate of patients infected with HCV genotype 2 is multifactorial. This is the first finding of a difference in viral dynamics between subtypes of the same virus and demonstrates the importance of subtype-specific virushost-drug interactions.

Original languageEnglish
Pages (from-to)28-35
Number of pages8
JournalJournal of Infectious Diseases
Volume182
Issue number1
DOIs
StatePublished - Jul 2000

Bibliographical note

Funding Information:
Financial support: Gonda-Goldschmied Medical Diagnostic Center and the Committee for the Advancement of Research of Bar-Ilan University; Santa Fe Institute; Schering Plough Corporation, Kenilworth, NJ; Joseph P. Sullivan and Jeanne M. Sullivan Foundation; and National Institutes of Health (grants RR06555, A1/DK41320-2, and A139049-2).

Funding

Financial support: Gonda-Goldschmied Medical Diagnostic Center and the Committee for the Advancement of Research of Bar-Ilan University; Santa Fe Institute; Schering Plough Corporation, Kenilworth, NJ; Joseph P. Sullivan and Jeanne M. Sullivan Foundation; and National Institutes of Health (grants RR06555, A1/DK41320-2, and A139049-2).

FundersFunder number
Committee for the Advancement of Research of Bar-Ilan University
Gonda-Goldschmied Medical Diagnostic Center
Schering Plough Corporation
National Institutes of HealthRR06555, A1/DK41320-2, A139049-2
National Institute of Allergy and Infectious DiseasesR29AI039049
Santa Fe Institute

    Fingerprint

    Dive into the research topics of 'Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus'. Together they form a unique fingerprint.

    Cite this